129 related articles for article (PubMed ID: 4064048)
1. Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1985; 8(1-2):287-90. PubMed ID: 4064048
[TBL] [Abstract][Full Text] [Related]
2. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1983; 6(1-2):293-6. PubMed ID: 6883387
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma.
Rasmuson T; Björk GR
Acta Oncol; 1995; 34(1):61-7. PubMed ID: 7865238
[TBL] [Abstract][Full Text] [Related]
4. [A clinical study of the non-Hodgkin's lymphomas according to the Kiel classification (author's transl)].
Stacher A; Heinz R; Waldner R
Arch Geschwulstforsch; 1979; 49(8):715-30. PubMed ID: 120730
[TBL] [Abstract][Full Text] [Related]
5. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
Stacher A; Heinz R; Waldner R; Böhnel J
Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
[TBL] [Abstract][Full Text] [Related]
6. Pseudouridine excretion in patients with psoriasis.
Clemmensen OJ; Kieffer M; Sjølin KE
Acta Derm Venereol; 1987; 67(4):310-4. PubMed ID: 2445149
[TBL] [Abstract][Full Text] [Related]
7. Urinary pseudouridine in patients with lymphoma: comparison with other clinical parameters.
Masaki Y; Itoh K; Sawaki T; Karasawa H; Kawanami T; Fukushima T; Kawabata H; Wano Y; Hirose Y; Suzuki T; Sugai S; Umehara H
Clin Chim Acta; 2006 Sep; 371(1-2):148-51. PubMed ID: 16643879
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of malignant lymphomas].
Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
[TBL] [Abstract][Full Text] [Related]
9. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.
Nyholm KK; Sjolin KE; Wolf H; Hammer M; Knudsen J; Stahl D; Nielsen HR
Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520
[TBL] [Abstract][Full Text] [Related]
10. Labeling index as a prognostic marker in non-Hodgkin's lymphomas.
Costa A; Bonadonna G; Villa E; Valagussa P; Silvestrini R
J Natl Cancer Inst; 1981 Jan; 66(1):1-5. PubMed ID: 6935451
[TBL] [Abstract][Full Text] [Related]
11. [Cytodiagnosis of malignant non-Hodgkin's lymphomas in effusions (author's transl)].
Wünsch PH; Müller HA
Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 36(2-3):275-90. PubMed ID: 6116340
[TBL] [Abstract][Full Text] [Related]
12. DNA-grading of malignant lymphomas. II. Correlation with clinical parameters.
Böcking A; Chatelain R; Auffermann W; Löhr GW; Reif M; Rossner R; Becker H
Anticancer Res; 1986; 6(5):1217-23. PubMed ID: 3800328
[TBL] [Abstract][Full Text] [Related]
13. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
14. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
[TBL] [Abstract][Full Text] [Related]
15. Malignant lymphoma: an update on diagnosis, staging, and management.
Perlin E
Prim Care; 1980 Sep; 7(3):409-22. PubMed ID: 6905202
[TBL] [Abstract][Full Text] [Related]
16. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
Tsartsidze E; Betaneli M
Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
[TBL] [Abstract][Full Text] [Related]
20. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]